Soleno Therapeutics (SLNO) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.83
-1.31
-0.79
-0.27

Details

Expected EPS
-0.605
Actual EPS
-1.83
Surprise EPS
-1.23
Surprise Percent
-202.48%

Description

⁨Soleno Therapeutics⁩ (⁦SLNO⁩) has reported earnings of ⁦-1.83⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts